Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing the link between BACH1 and BRCA1 in the FA pathway.

Sharon B Cantor1, Paul R Andreassen

  • 1Department of Cancer Biology, University of Massachusetts Medical School, Women's Cancers Program, UMASS Memorial Cancer Center, Worcester, Massachusetts 01605, USA. Sharon.Cantor@umassmed.edu

Cell Cycle (Georgetown, Tex.)
|December 17, 2005
PubMed
Summary

BRCA1 may regulate BACH1 helicase activity, impacting DNA repair and genomic stability in Fanconi anemia (FA). This interaction is crucial for understanding FA pathway function and maintaining chromosomal integrity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights and modulation of RNA polymerase-dependent R-loop and dsRNA in Fanconi anemia hematopoietic stem cells.

JCI insight·2026
Same author

RAD51 is chromatin enriched and targetable in BRCA1-deficient cells.

Molecular cell·2025
Same author

Reclassification of ATM Missense Variants of Uncertain Significance by Integrating Results from Systematic Functional Assays into an ACMG Points-Based Framework.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability.

Nature cancer·2025
Same author

Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells.

The Journal of clinical investigation·2025
Same author

Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer.

DNA repair·2024

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • The BACH1 helicase binds BRCA1, linking it to hereditary breast cancer.
  • BACH1 is the gene defective in Fanconi anemia (FA) group J, a disorder causing DNA damage sensitivity and genomic instability.
  • BACH1 functions downstream in the FA pathway, similar to BRCA2/FANCD1, as FANCD2 monoubiquitination is unaffected in BACH1-deficient cells.

Purpose of the Study:

  • To review the connection between BRCA1 and BACH1 within the Fanconi anemia (FA) pathway.
  • To propose a model where BRCA1 regulates BACH1 activity to maintain genomic stability.

Main Methods:

  • Literature review focusing on the FA pathway and protein interactions.
  • Analysis of existing data on BACH1 and BRCA1 function in DNA repair.

Related Experiment Videos

Main Results:

  • BRCA1 has interactions with FA proteins but is not identified as an FA gene.
  • BACH1 deficiency does not affect FANCD2 monoubiquitination, suggesting a downstream role in the FA pathway.

Conclusions:

  • BRCA1 is predicted to regulate BACH1 helicase activity.
  • This regulation likely coordinates Rad51 displacement from nucleofilaments, promoting accurate DNA repair and preserving chromosomal integrity.